The FDA warned Tuesday that those relying on a rapid test to see if they’ve contracted COVID-19 should double down on them.
Initial results from National Institutes of Health studies show that antigen tests may be less reliable in detecting the highly transmissible Omicron variant, and most antigen tests should be done twice, on two separate days. “Early data suggests that antigen tests do detect the Omicron variant but may have reduced sensitivity,”.
It recommended those seeking the most reliable results get a PCR test, as that detects the virus on a molecular level. “Although the data is preliminary, the FDA believes it is important to share with the public,” a spokesperson told Politico. “We will continue to keep the public informed if additional information comes to light.”
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
High demand, low supply postpones 'miracle' FDA-approved weight loss drug to mid-2022The first FDA-approved weight loss drug since 2014 will not be available to consumers due to manufacturing and delivery issues.
Lire la suite »
FDA-approved Vuity eyedrops could replace your reading glassesHow do Vuity eyedrops work? How much do they cost? Experts discuss what consumers should know about FDA-approved product.
Lire la suite »
The FDA Has Approved Abortion Pills by MailHere’s what you should know about medication abortion.
Lire la suite »
North Dallas COVID-19 Testing Site Sees Positivity Rates Climb to 30%As the omicron variant fuels a sharp rise in COVID-19 cases, more North Texans are seeking out drive-thru rapid testing.
Lire la suite »
Fauci admits US needs to ‘do better’ with at-home COVID tests, warns cases will riseDr. Anthony Fauci explained that the rapid COVID-19 tests have become more difficult to come by due to the surge of cases caused by the Omicron variant.
Lire la suite »